Beijing Keyifeng Biotech

Beijing Keyifeng Biotech is a Chinese biopharmaceutical company specializing in the development of recombinant protein therapeutics and high-end diagnostic reagents. Founded in 2014 and based in the Beijing Economic-Technological Development Area, the company focuses on creating bio-better versions of established biologics with improved pharmacological properties. Its lead candidate is a long-acting recombinant human growth hormone designed to reduce the burden of daily injections for patients. Keyifeng leverages proprietary platforms for protein engineering, high-density cell culture, and purification to advance its internal pipeline and provide CDMO services. The company serves both the clinical market and the broader life sciences research community through its catalog of specialized reagents.